11.81
price down icon0.92%   -0.11
after-market アフターアワーズ: 11.81
loading
前日終値:
$11.92
開ける:
$11.9
24時間の取引高:
1.39M
Relative Volume:
0.76
時価総額:
$3.77B
収益:
$3.05B
当期純損益:
$181.32M
株価収益率:
31.60
EPS:
0.3737
ネットキャッシュフロー:
$225.64M
1週間 パフォーマンス:
-6.27%
1か月 パフォーマンス:
-15.10%
6か月 パフォーマンス:
+2.52%
1年 パフォーマンス:
+57.47%
1日の値動き範囲:
Value
$11.76
$12.04
1週間の範囲:
Value
$11.76
$12.64
52週間の値動き範囲:
Value
$7.02
$15.42

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
名前
Amneal Pharmaceuticals Inc
Name
セクター
Healthcare (1105)
Name
電話
908-947-3120
Name
住所
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
職員
5,210
Name
Twitter
@amnealpharma
Name
次回の収益日
2026-05-01
Name
最新のSEC提出書
Name
AMRX's Discussions on Twitter

Compare AMRX vs TAK, HLN, TEVA, ZTS, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
AMRX icon
AMRX
Amneal Pharmaceuticals Inc
11.81 3.80B 3.05B 181.32M 225.64M 0.3737
TAK icon
TAK
Takeda Pharmaceutical Co Adr
16.58 52.36B 29.91B 1.30B 3.49B 0.4056
HLN icon
HLN
Haleon Plc Adr
9.20 40.62B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
34.07 39.63B 17.53B 1.58B 444.18M 1.3457
ZTS icon
ZTS
Zoetis Inc
78.92 32.58B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
566.80 24.07B 3.17B 1.29B 1.01B 27.09

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-17 開始されました UBS Buy
2025-12-09 開始されました Barclays Overweight
2025-06-06 開始されました Goldman Buy
2025-02-24 アップグレード JP Morgan Neutral → Overweight
2024-09-06 アップグレード JP Morgan Underweight → Neutral
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2021-03-08 アップグレード Goldman Sell → Buy
2020-12-14 アップグレード Barclays Equal Weight → Overweight
2020-12-14 アップグレード Guggenheim Neutral → Buy
2020-07-27 開始されました Goldman Sell
2020-05-12 アップグレード Guggenheim Sell → Neutral
2019-12-12 ダウングレード Raymond James Outperform → Mkt Perform
2019-11-12 ダウングレード JP Morgan Neutral → Underweight
2019-11-07 ダウングレード SVB Leerink Outperform → Mkt Perform
2019-07-22 アップグレード SVB Leerink Mkt Perform → Outperform
2019-07-11 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2019-07-08 アップグレード Piper Jaffray Neutral → Overweight
2019-06-11 開始されました Barclays Equal Weight
2019-05-21 アップグレード Raymond James Mkt Perform → Strong Buy
2019-03-20 開始されました SunTrust Buy
2019-03-08 ダウングレード SVB Leerink Outperform → Mkt Perform
2018-12-14 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-10-16 ダウングレード SunTrust Buy → Hold
2018-08-13 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-07-23 開始されました Morgan Stanley Overweight
2018-06-22 開始されました B. Riley FBR, Inc. Buy
すべてを表示

Amneal Pharmaceuticals Inc (AMRX) 最新ニュース

pulisher
May 19, 2026

Amneal rated buy in new research coverage at UBS as growth pipeline expands - MSN

May 19, 2026
pulisher
May 19, 2026

Amneal Shareholders Back Board, Pay and Auditor at Meeting - TipRanks

May 19, 2026
pulisher
May 18, 2026

Should value investors buy Amneal Pharmaceuticals (AMRX) stock? - MSN

May 18, 2026
pulisher
May 18, 2026

Why Amneal Pharmaceuticals (AMRX) is a top growth stock for the long term - MSN

May 18, 2026
pulisher
May 18, 2026

Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term - Yahoo Finance

May 18, 2026
pulisher
May 17, 2026

Amneal Pharmaceuticals, Inc.Class A Common Stock (Nasdaq:AMRX) Stock Quote - The Chronicle-Journal

May 17, 2026
pulisher
May 16, 2026

AMRX Should I Buy - Intellectia AI

May 16, 2026
pulisher
May 15, 2026

3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX) - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock? - Yahoo Finance

May 15, 2026
pulisher
May 15, 2026

Here's why Amneal Pharmaceuticals (AMRX) is a strong growth stock - MSN

May 15, 2026
pulisher
May 14, 2026

Amneal Pharmaceuticals' (NASDAQ:AMRX) Solid Earnings Are Supported By Other Strong Factors - Yahoo Finance

May 14, 2026
pulisher
May 13, 2026

AMRX growth drivers: Generics, biosimilars, and Crexont - MSN

May 13, 2026
pulisher
May 13, 2026

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Weakness - Sahm

May 13, 2026
pulisher
May 12, 2026

Amneal (AMRX) director Deborah Autor sells 34,819 shares at $12.94 avg - Stock Titan

May 12, 2026
pulisher
May 11, 2026

[144] Amneal Pharmaceuticals, Inc. SEC Filing - Stock Titan

May 11, 2026
pulisher
May 10, 2026

Do options traders know something about Amneal stock we don't? - MSN

May 10, 2026
pulisher
May 10, 2026

Amneal (AMRX) Q3 2025 Earnings Call Transcript - AOL.com

May 10, 2026
pulisher
May 10, 2026

AMRX SEC FilingsAmneal Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

May 10, 2026
pulisher
May 09, 2026

Amneal to buy Kashiv in $750M deal; raises FY26 EPS outlook - MSN

May 09, 2026
pulisher
May 09, 2026

Amneal Pharmaceuticals (AMRX) Profit Rebound Challenges Concerns Over Earnings Quality - Sahm

May 09, 2026
pulisher
May 08, 2026

[Form 4] Amneal Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BUCHI J KEVIN - Moomoo

May 08, 2026
pulisher
May 08, 2026

Amneal (NYSE: AMRX) director exercises 34,819 RSUs and receives new grant - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Amneal (NYSE: AMRX) director settles RSUs, now holds 128,479 shares - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Amneal Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director George Jeffrey P. - Moomoo

May 08, 2026
pulisher
May 08, 2026

Amneal (AMRX) director Jeffrey George exercises 34,819 RSUs, receives 19,824 new units - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Amneal (AMRX) director exercises RSUs, now holds 260,252 shares - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Director boosts stake with 34,819 shares in Amneal (NYSE: AMRX) - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Amneal (NYSE: AMRX) director exercises 48,747 RSUs and receives 30,837-unit grant - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Amneal (NYSE: AMRX) director converts RSUs to shares and gets new grant - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised) - Yahoo Finance

May 08, 2026
pulisher
May 07, 2026

Amneal Pharmaceuticals Q1 2026 & M&A announcement Earnings Call Transcript - MarketBeat

May 07, 2026
pulisher
May 07, 2026

Amneal Pharmaceuticals (NASDAQ: AMRX) posts Q1 profit surge and inks $375M Kashiv acquisition - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Drugmaker Amneal posts $62M profit as specialty-drug sales rise 23% - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Amneal (NASDAQ: AMRX) investors back directors, say-on-pay and EY as auditor - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Earnings Flash (AMRX) Amneal Pharmaceuticals, Inc. Posts Q1 Adjusted EPS $0.27 per Share, vs. FactSet Est of $0.17 - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Earnings Flash (AMRX) Amneal Pharmaceuticals, Inc. Reports Q1 Revenue $722.5M, vs. FactSet Est of $719.7M - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Amneal (NASDAQ: AMRX) Q1 2026 profit soars as margins rise and guidance held - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Amneal Reports First Quarter 2026 Financial Results - The Manila Times

May 07, 2026
pulisher
May 07, 2026

Earnings Flash (AMRX) Amneal Pharmaceuticals, Inc. Reports Q1 Revenue $722.5M, Vs. FactSet Est of $719.7M - Moomoo

May 07, 2026
pulisher
May 07, 2026

Earnings Flash (AMRX) Amneal Pharmaceuticals, Inc. Posts Q1 Adjusted EPS $0.27 per Share, Vs. FactSet Est of $0.22 - Moomoo

May 07, 2026
pulisher
May 07, 2026

Number of shareholders of Amneal Pharmaceuticals, Inc. – NASDAQ:AMRX - TradingView

May 07, 2026
pulisher
May 07, 2026

Amneal Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026
pulisher
May 06, 2026

Vishrut Awasthi Joins Amneal Pharmaceuticals to Lead India Strategy and Business Development - hrtoday.in

May 06, 2026
pulisher
May 05, 2026

Amneal Pharmaceuticals Kashiv Deal Puts Biosimilar Growth And Valuation In Focus - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Do Options Traders Know Something About Amneal Stock We Don't? - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

How The Amneal Pharmaceuticals (AMRX) Story Is Shifting Around The New US$17 Price Target - Yahoo Finance

May 05, 2026
pulisher
May 05, 2026

Earnings call transcript: Amneal Pharma Q1 2026 Surpasses EPS Forecast By Investing.com - Investing.com Nigeria

May 05, 2026
pulisher
May 05, 2026

Earnings call transcript: Amneal Pharma Q1 2026 Surpasses EPS Forecast - Investing.com

May 05, 2026

Amneal Pharmaceuticals Inc (AMRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$19.80
price down icon 0.65%
RDY RDY
$13.45
price down icon 1.10%
RGC RGC
$27.00
price down icon 2.84%
$154.36
price down icon 1.81%
$16.17
price down icon 2.00%
$566.80
price down icon 0.03%
大文字化:     |  ボリューム (24 時間):